Nov 09, 2023

Hear What Colin Hill had to say to Sidley on AI Use in Drug Discovery

Stephen Abreu, Sidley partner, talks to our Colin Hill about how the use of AI is revolutionizing the biotech space.

Colin explains how our ability to predict and understand the actions of biological systems has historically been limited because of the complexity of “genetic circuitry,” but AI has allowed us to develop a more quantitative and predictive understanding of the actions of biological systems. This has very practical implications for oncology and new treatments for Parkinson’s and Alzheimer’s. They also discuss how AI can be deployed on “undruggable” targets, and how the Aitia’s Digital Twins can be utilized with the goal of discovering novel combinations of drug targets.

Listen to this episode here.